Anavex Life Sciences AVXL
NASDAQ AVXL
$1.40 +0.04 (+2.94%)
As of: Oct 22, 2026 · 10:53 AM EDT

Anavex Life Sciences (AVXL) EBITDA Margin (2016)

Updated

Analysis

Anavex Life Sciences (AVXL) EBITDA Margin (2016) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin (Qtr)
1 Eli Lilly 1,166.78 Bn 1,135.37 Bn 19.71 Bn 53.49%
2 Johnson & Johnson 635.34 Bn 553.86 Bn 17.26 Bn 35.95%
3 AbbVie 503.48 Bn 476.60 Bn 12.70 Bn 49.01%
4 Merck 377.08 Bn 331.46 Bn 12.21 Bn 6.02%
5 Novartis Ag 304.13 Bn 268.12 Bn 11.24 Bn -
6 Astrazeneca 267.48 Bn 241.16 Bn 12.86 Bn 33.11%
7 Amgen 241.75 Bn 197.15 Bn 7.24 Bn 46.01%
8 Gilead Sciences 194.09 Bn 168.29 Bn 6.22 Bn -124.26%
9 Pfizer 172.59 Bn 119.24 Bn 10.94 Bn 39.16%
10 Anavex Life Sciences 128.85 Mn -351.23 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2016 -144,866.95%
Jun 30, 2016 -85,076.43%
API Access

Anavex Life Sciences EBITDA Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebitda-margin&ticker=AVXL&period=max&api_key=YOUR_API_KEY